Deciphera Pharmaceuticals Alternatives & Competitors
12 companies similar to Deciphera Pharmaceuticals — A member of ONO Group
Companies similar to Deciphera Pharmaceuticals
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Merck & Co., Inc.
Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...
Blueprint Medicines
Striving to improve and extend patients' lives
Cambridge, United States
Seattle, United States
Rival Readout
Competing with Deciphera Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
BeyondSpring
Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to ad...
New York, United States
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
United States
BeiGene
BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company
Cambridge, United States
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
AlloMek Therapeutics LLC
Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.
Pepkon
Pioneering breakthrough peptides for treating challenging cancers with precision and hope.
Paris, France
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
About Deciphera Pharmaceuticals
Deciphera Pharmaceuticals, under the slogan A member of ONO Group, is a noteworthy player in the biopharmaceutical sector, dedicated to innovating crucial cancer treatments. Established in 2003, the company leverages a proprietary switch-control kinase inhibitor platform that capitalizes on extensive kinase biology exp...
Design and Development of Kinase Inhibitors, Clinical Trials and Studies, Expanded Access Program, Patient Response Improvement Programs
Patients with Cancer, Healthcare Professionals, Pharmaceutical Partners, Clinical Researchers
Biopharmaceutical, Cancer Treatment, Medicines Development, Switch-control Kinase Inhibitors, Kinase Biology, Drug Discovery, Oncology, Innovation In Medicine, Pharmaceutical Research, Tumor Treatment, Biotech Innovation, Kinase Inhibitor Platform
B2B, B2C, D2C
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Deciphera Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Deciphera Pharmaceuticals on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
